Evidence Generation Intern
Genmab
Summary
The Evidence Generation Intern supports Genmab's drug development efforts by working directly with the team to deliver on Evidence Generation programs. This position will be responsible for supporting operational aspects of Investigator-Driven Programs: Investigator-Sponsored trials (ISTs), Collaborative Research Trials (CRTs), Managed Access Programs (Individual and Protocol) and other Evidence Generation initiatives within Medical Affairs.
Job description
Job Overview
The Evidence Generation Intern supports Genmab's drug development efforts by working directly with the team to deliver on Evidence Generation programs. This position will be responsible for supporting operational aspects of Investigator-Driven Programs: Investigator-Sponsored trials (ISTs), Collaborative Research Trials (CRTs), Managed Access Programs (Individual and Protocol) and other Evidence Generation initiatives within Medical Affairs.
What You'll Do
- Participate in successful implementation of Investigator-Driven and Managed Access Programs
- Support different governance meetings to drive and deliver on Evidence Generation Programs
- Support operational timelines and key deliverables
- Facilitate management of study or program proposal lifecycle from submission to study closure
- Support successful management of all aspects of investigator-driven programs within designated program budgets and timelines
- Collaborate with cross-functional teams and partners to manage, adjust, and revise project milestones as necessary
- Collaborate with EvGen team to generate regular metrics and reports of program activities
- Participate in mentorship meetings and contribute to team discussions on process improvements and best practices
Required Qualifications, Capabilities And Skills
- Enrolled in a Bachelor's or Advanced degree in a scientific discipline
- Strong analytical and problem-solving abilities
- Excellent written and verbal communication skills
- Ability to work independently and as part of a collaborative team
- Maintains attention to detail and quality in all deliverables while managing multiple tasks
Preferred Qualifications, Capabilities And Skills
- Basic understanding of clinical research is preferred
- Demonstrates initiative, a proactive attitude, and eagerness to learn in a fast-paced environment
- Effectively communicates and collaborates with team members, mentors, and stakeholders
General Intern Information
Internships will take place over 10 weeks from June – August 2027. This role will be based in Princeton, NJ and operate on a required hybrid schedule – 3 days in the office and 2 days remote per week. This role is not eligible for work visa sponsorship at the time of the application or in the future.
Requirements
- Enrolled in a Bachelor's or Advanced degree in a scientific discipline
- Strong analytical and problem-solving abilities
- Excellent written and verbal communication skills
- Ability to work independently and as part of a collaborative team
- Maintains attention to detail and quality in all deliverables while managing multiple tasks
- Basic understanding of clinical research is preferred
- Demonstrates initiative, a proactive attitude, and eagerness to learn in a fast-paced environment
- Effectively communicates and collaborates with team members, mentors, and stakeholders
Company overview
Genmab is a leading international biotechnology company headquartered in Copenhagen, Denmark, specializing in the development and commercialization of differentiated antibody therapeutics for the treatment of cancer. Founded in 1999, the company has established itself as a pioneer in antibody technology with its proprietary DuoBody, HexaBody, and DuoHexaBody platforms. Genmab's innovative approach focuses on creating next-generation antibody-based therapies that target specific cancer cells while minimizing damage to healthy tissues. The company has several marketed products including DARZALEX (daratumumab) for multiple myeloma, which has become a cornerstone treatment in hematological malignancies. Genmab's pipeline includes numerous clinical-stage candidates targeting various cancers, leveraging its expertise in antibody engineering to develop novel immunotherapies. The company collaborates with major pharmaceutical partners worldwide and maintains a strong commitment to advancing cancer treatment through cutting-edge science and patient-focused innovation.